Works matching IS 00099104 AND DT 2020 AND VI 200 AND IP 3

Results: 10

Integrated omics analysis of sweat reveals an aberrant amino acid metabolism pathway in Vogt–Koyanagi–Harada disease.
Published in:
Clinical & Experimental Immunology, 2020, v. 200, n. 3, p. 250, doi. 10.1111/cei.13435
By:
- Cui, X.;
- Su, G.;
- Zhang, L.;
- Yi, S.;
- Cao, Q.;
- Zhou, C.;
- Kijlstra, A.;
- Yang, P.
Publication type:
Article
Exogenous interleukin‐2 can rescue in‐vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutation.
Published in:
Clinical & Experimental Immunology, 2020, v. 200, n. 3, p. 215, doi. 10.1111/cei.13432
By:
- Shamriz, O.;
- Simon, A. J.;
- Lev, A.;
- Megged, O.;
- Ledder, O.;
- Picard, E.;
- Joseph, L.;
- Molho-Pessach, V.;
- Tal, Y.;
- Millman, P.;
- Slae, M.;
- Somech, R.;
- Toker, O.;
- Berger, M.
Publication type:
Article
ELISPOT assays and their diagnostic potential in Lyme disease and Lyme neuroborreliosis.
Published in:
Clinical & Experimental Immunology, 2020, v. 200, n. 3, p. 299, doi. 10.1111/cei.13431
By:
- Ettischer‐Schmid, N.;
- Preyer, R.
Publication type:
Article
Serum immunoglobulin G antibody titer to Fusobacterium nucleatum is associated with unfavorable outcome after stroke.
Published in:
Clinical & Experimental Immunology, 2020, v. 200, n. 3, p. 302, doi. 10.1111/cei.13430
By:
- Nishi, H.;
- Hosomi, N.;
- Ohta, K.;
- Aoki, S.;
- Nakamori, M.;
- Nezu, T.;
- Shigeishi, H.;
- Shintani, T.;
- Obayashi, T.;
- Ishikawa, K.;
- Kinoshita, N.;
- Shiga, Y.;
- Sugiyama, M.;
- Ohge, H.;
- Maruyama, H.;
- Kawaguchi, H.;
- Kurihara, H.
Publication type:
Article
Vitamin D status and the immune assessment in 22q11.2 deletion syndrome.
Published in:
Clinical & Experimental Immunology, 2020, v. 200, n. 3, p. 272, doi. 10.1111/cei.13429
By:
- Legitimo, A.;
- Bertini, V.;
- Costagliola, G.;
- Baroncelli, G. I.;
- Morganti, R.;
- Valetto, A.;
- Consolini, R.
Publication type:
Article
Co‐occurrence of IgE and IgG autoantibodies in patients with chronic spontaneous urticaria.
Published in:
Clinical & Experimental Immunology, 2020, v. 200, n. 3, p. 242, doi. 10.1111/cei.13428
By:
- Asero, R.;
- Marzano, A. V.;
- Ferrucci, S.;
- Lorini, M.;
- Carbonelli, V.;
- Cugno, M.
Publication type:
Article
STIM1 knock‐down decreases the affinity of obinutuzumab for CD20 by altering CD20 localization to Triton‐soluble membrane.
Published in:
Clinical & Experimental Immunology, 2020, v. 200, n. 3, p. 260, doi. 10.1111/cei.13427
By:
- Heo, W.;
- Jin, N.;
- Park, M. S.;
- Kim, H.‐Y.;
- Yoon, S. M.;
- Lee, J.;
- Kim, J. Y.
Publication type:
Article
IgG antibody response against Plasmodium falciparum aminopeptidase 1 antigen in Gabonese children living in Makokou and Franceville.
Published in:
Clinical & Experimental Immunology, 2020, v. 200, n. 3, p. 287, doi. 10.1111/cei.13425
By:
- Oyegue‐Liabagui, S. L.;
- Imboumy‐Limoukou, R.‐K.;
- Kouna, C. L.;
- Bangueboussa, F.;
- Schmitt, M.;
- Florent, I.;
- Lekana‐Douki, J. B.
Publication type:
Article
Low‐dose IL‐2 induces CD56<sup>bright </sup>NK regulation of T cells via NKp44 and NKp46.
Published in:
Clinical & Experimental Immunology, 2020, v. 200, n. 3, p. 228, doi. 10.1111/cei.13422
By:
- McQuaid, S. L.;
- Loughran, S. T.;
- Power, P. A.;
- Maguire, P.;
- Szczygiel, A.;
- Johnson, P. A.
Publication type:
Article
Issue Information.
Published in:
Clinical & Experimental Immunology, 2020, v. 200, n. 3, p. 1, doi. 10.1111/cei.13322
Publication type:
Article